IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
1-Year Return
40.53%
This Quarter Return
+13.69%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$849M
AUM Growth
-$155M
(-15%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-24.68%
Top 10 Holdings %
Top 10 Hldgs %
53.19%
Holding
100
New
29
Increased
13
Reduced
14
Closed
35
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$33.8M |
| 2 |
Medtronic
MDT
|
$27M |
| 3 |
Cooper Companies
COO
|
$12.1M |
| 4 |
Fresenius Medical Care
FMS
|
$9.59M |
| 5 |
Bristol-Myers Squibb
BMY
|
$9.05M |
Top Sells
| 1 |
Elevance Health
ELV
|
$43.3M |
| 2 |
Humana
HUM
|
$28M |
| 3 |
Universal Health Services
UHS
|
$24M |
| 4 |
Becton Dickinson
BDX
|
$17.5M |
| 5 |
Cigna
CI
|
$16.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$666B
| $8.86M | 1% |
10,000
| – | – |
|
27
DexCom
DXCM
$31.7B
| $8.04M | 0.91% |
+120,000
| New | +$8.04M |
|
28
Catalyst Pharmaceutical
CPRX
$2.42B
| $7.95M | 0.89% |
400,000
+125,000
| +45% | +$2.49M |
|
29
Sana Biotechnology
SANA
$757M
| $7.49M | 0.84% |
1,800,000
+600,000
| +50% | +$2.5M |
|
30
Teleflex
TFX
$5.7B
| $7.42M | 0.83% |
30,000
-15,000
| -33% | -$3.71M |
|
31
BrightSpring Health Services
BTSG
$4.27B
| $7.34M | 0.83% |
+500,000
| New | +$7.34M |
|
32
CRISPR Therapeutics
CRSP
$4.8B
| $7.05M | 0.79% |
150,000
| – | – |
|
33
Alnylam Pharmaceuticals
ALNY
$59.4B
| $6.88M | 0.77% |
+25,000
| New | +$6.88M |
|
34
Applied Therapeutics
APLT
$67M
| $6.8M | 0.77% |
+800,000
| New | +$6.8M |
|
35
Jasper Therapeutics
JSPR
$43.7M
| $6.58M | 0.74% |
+350,000
| New | +$6.58M |
|
36
Tandem Diabetes Care
TNDM
$837M
| $6.36M | 0.72% |
+150,000
| New | +$6.36M |
|
37
BioNTech
BNTX
$24.9B
| $5.94M | 0.67% |
+50,000
| New | +$5.94M |
|
38
QuidelOrtho
QDEL
$1.89B
| $5.7M | 0.64% |
125,000
-25,000
| -17% | -$1.14M |
|
39
Viridian Therapeutics
VRDN
$1.52B
| $5.69M | 0.64% |
+250,000
| New | +$5.69M |
|
40
Evolent Health
EVH
$1.1B
| $5.66M | 0.64% |
+200,000
| New | +$5.66M |
|
41
Exact Sciences
EXAS
$9.73B
| $5.45M | 0.61% |
+80,000
| New | +$5.45M |
|
42
IQVIA
IQV
$31.3B
| $4.74M | 0.53% |
+20,000
| New | +$4.74M |
|
43
Tenaya Therapeutics
TNYA
$202M
| $4.58M | 0.52% |
2,375,000
+50,000
| +2% | +$96.5K |
|
44
Twist Bioscience
TWST
$1.55B
| $4.52M | 0.51% |
+100,000
| New | +$4.52M |
|
45
Nurix Therapeutics
NRIX
$697M
| $4.49M | 0.51% |
200,000
+50,000
| +33% | +$1.12M |
|
46
Mineralys Therapeutics
MLYS
$2.2B
| $4.31M | 0.49% |
+356,000
| New | +$4.31M |
|
|
MREO
47
Mereo BioPharma
MREO
$275M
| $4.11M | 0.46% |
1,000,000
-775,000
| -44% | -$3.19M |
|
48
Revvity
RVTY
$9.95B
| $3.83M | 0.43% |
+30,000
| New | +$3.83M |
|
49
89bio
ETNB
$1.28B
| $3.7M | 0.42% |
500,000
+50,000
| +11% | +$370K |
|
50
Myriad Genetics
MYGN
$632M
| $3.42M | 0.39% |
+125,000
| New | +$3.42M |
|